VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis-Reference-Cited by-同舟云学术

VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis

Published:2022-10 Issue: Volume:135 Page:155274
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Jia Xiong,Bai Xiangli,Yang Xiaoyan,Wang Ling,Lu Yajing,Zhu Lin,Zhao Ying,Cheng Wenzhuo,Shu Meng,Mei Qiyong,Jin Si

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference49 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel;Ference;Eur Heart J,2017

2. The changing landscape of atherosclerosis;Libby;Nature,2021

3. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting;Soppert;Adv Drug Deliv Rev,2020

4. SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis;Huang;Nature,2019

5. Caveolin-1 regulates atherogenesis by attenuating low-density lipoprotein transcytosis and vascular inflammation independently of endothelial nitric oxide synthase activation;Ramírez;Circulation,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics;ACS Nano;2024-08-14

2. Targeting noncoding RNAs to treat atherosclerosis;British Journal of Pharmacology;2024-05-08

3. Shear-Sensitive circRNA-LONP2 Promotes Endothelial Inflammation and Atherosclerosis by Targeting NRF2/HO1 Signaling;JACC: Basic to Translational Science;2024-05

4. VCAM-1-Targeted Nanoparticles to Diagnose, Monitor and Treat Atherosclerosis;Nanomedicine;2024-03-22

5. Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases;Frontiers in Bioengineering and Biotechnology;2024-01-18